← Back to Portfolio

Tizona Therapeutics

Tizona Therapeutics is a US immunotherapy company developing a pipeline of novel antibody therapeutics with potential in a broad range of cancers and autoimmune diseases. Tizona’s lead candidate is expected to start clinical trials in 2018 for cancer.  

LocationSouth San Francisco, California
CEOLuke Evnin, Executive Chairman
PartnerShelley Chu
Websitewww.tizonatx.com